ARCA:PSIL

AdvisorShares Psychedelics ETF

$ 16.5082 -0.4308 ( -2.54%) 03:33 PM EST
PE Ratio:
2.92
PB Ratio:
0.97
Volume:
29.56K
Dividend Yield %:
2.29
Last Holding update 2025-06-23 25 Stocks (3 new)
Value $8.00 Mil Turnover 34 %
Top Holdings: MNMD(8.66%) SAGE(8.23%) ALKS(8.17%) NRXP(7.28%) ATAI(6.88%)
Portfolio Report
Registrant: AdvisorShares Trust
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

AdvisorShares Psychedelics ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

AdvisorShares Psychedelics ETF Key Statistics

Name Value
Day's Open ($) 16.94
Day's Range ($) 16.1894 - 16.94
Day's Volume 29,557
52-Week Range ($) 7.14 - 16.99
Beta 0.74
3-Year Sharpe Ratio -0.22
3-Year Sortino Ratio -0.35
Volatility 67.75
14-Day RSI 76.76
14-Day ATR ($) 0.451027
20-Day SMA ($) 14.76845

Fundamental Data

Name Value
Market Cap (Mil $) 12.381
Shares Outstanding (Mil) 0.75
PE Ratio 2.92
PE Ratio (10y Range) 3.51 - 50.62
PE Ratio (10y Median) 19.08
PB Ratio 0.97
PB Ratio (10y Range) 0.98 - 3.77
PB Ratio (10y Median) 1.78

Dividend Data

Name Value
Dividends per Share (TTM) ($) 0.379
Dividend Yield % 2.29
Dividend Yield % (10y Range) 1.44 - 14.37
Dividend Yield % (10y Median) 8.59
Next Dividend Payment Date
Dividend Frequency Quarterly

PSIL AdvisorShares Psychedelics ETF Fundamental Charts

Historical TTM Price-to-Earnings for PSIL AdvisorShares Psychedelics ETF

Historical TTM Price-to-Earnings without NRI for PSIL AdvisorShares Psychedelics ETF

Historical Price-to-Book Ratio for PSIL AdvisorShares Psychedelics ETF

Historical Dividend Yields for PSIL AdvisorShares Psychedelics ETF

AdvisorShares Psychedelics ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:PSIL

No Available Data

ARCA:PSIL is held by these investors

No Available Data
AdvisorShares Psychedelics ETF... Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MNMD
Mind Medicine Inc
119,593
699.6
+15.32%
8.660
+1.15%
0.160
+66.21%
+38.51%
728.3
Biotechnology
SAGE
Sage Therapeutics Inc
83,642
665.0
+74.98%
8.230
+3.53%
0.130
+13.93%
+61.14%
547.9
Biotechnology
ALKS
Alkermes PLC
19,975
659.6
+51.66%
8.170
+2.78%
0.010
-0.30%
-6.02%
4,457.3
Drug Manufacturers
NRXP
NRX Pharmaceuticals Inc
286,797
587.9
-7.58%
7.280
-0.91%
1.660
+56.54%
+35.91%
58.3
Biotechnology
ATAI
ATAI Life Sciences NV
408,762
555.9
0%
6.880
0%
0.190
+140.14%
+165.41%
748.9
Biotechnology
STIM
Neuronetics Inc
120,534
443.6
+978.60%
5.490
+4.98%
0.180
+3.69%
+162.11%
279.0
Medical Devices & Instruments
DRUG
Bright Minds Biosciences Inc
11,281
406.9
+266.86%
5.040
+3.67%
0.160
-21.15%
-26.67%
183.7
Biotechnology
ITCI
Intra-Cellular Therapies Inc
3,077
405.9
-5.70%
5.030
-0.27%
0.000
+57.89%
+57.89%
14,047.0
Drug Manufacturers
CMPS
Compass Pathways PLC
140,541
401.9
+111.02%
4.980
+2.62%
0.150
+23.81%
+16.93%
413.5
Healthcare Providers & Services
NEUP
Neuphoria Therapeutics Inc
69,659
401.2
New Holding
4.970
+4.97%
3.710
+52.48%
+124.49%
14.5
Biotechnology

AdvisorShares Psychedelics ETF's Historical Top Holdings Breakdowns

AdvisorShares Psychedelics ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
STIM
Neuronetics Inc
2025-03-31
Add
Add
+4.98%
●
1.49 ($3.65) 5.42
$4.22
15.62%
Add 978.6%
120,534
109,359
NEUP
Neuphoria Therapeutics Inc
2025-03-31
New Buy
New Buy
+4.97%
●
2.93 ($4.68) 5.8
$7.70
64.53%
New holding
69,659
69,659
DRUG
Bright Minds Biosciences Inc
2025-03-31
Add
Add
+3.67%
●
29.86 ($36.6) 46.29
$26.41
-27.83%
Add 266.86%
11,281
8,206
SAGE
Sage Therapeutics Inc
2025-03-31
Add
Add
+3.53%
●
5.55 ($7.32) 8.66
$8.75
19.54%
Add 74.98%
83,642
35,842
ALKS
Alkermes PLC
2025-03-31
Add
Add
+2.78%
●
28.08 ($32.61) 36
$27.03
-17.11%
Add 51.66%
19,975
6,804
CMPS
Compass Pathways PLC
2025-03-31
Add
Add
+2.62%
●
2.86 ($3.84) 4.99
$4.42
15.10%
Add 111.02%
140,541
73,939
NBIX
Neurocrine Biosciences Inc
2025-03-31
Add
Add
+2.10%
●
107.22 ($126.68) 153.29
$132.75
4.79%
Add 75.67%
3,566
1,536
VTGN
Vistagen Therapeutics Inc
2025-03-31
Add
Add
+1.84%
●
2.49 ($2.83) 3.34
$2.54
-10.25%
Add 59.42%
159,114
59,304
SILO
SILO Pharma Inc
2025-03-31
New Buy
New Buy
+1.80%
●
0.95 ($1.49) 1.98
$0.63
-57.58%
New holding
124,236
124,236
QNTM
Quantum BioPharma Ltd
2025-03-31
Reduce
Reduce
-1.30%
●
2.91 ($5.75) 14.5
$21.86
280.17%
Reduce -29.08%
48,990
-20,088

AdvisorShares Psychedelics ETF Total Holding History ($B)

To

AdvisorShares Psychedelics ETF's Asset Allocation

To

AdvisorShares Psychedelics ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

AdvisorShares Psychedelics ETF's Hypothetical Growth since 2025-03-31

AdvisorShares Psychedelics ETF's Yearly Returns

Year Portfolio % % Excess Gain %

AdvisorShares Psychedelics ETF's Holdings Heat Map

Size field:

AdvisorShares Psychedelics ETF's Holdings Bubble Chart

AdvisorShares Psychedelics ETF News

  • 1

Discussions on AdvisorShares Psychedelics ETF

User's Avatar
How would you rate this stock? PSIL
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.